Lineage Cell Therapeutics announces annual shareholder meeting

LINEAGE CELL THERAPEUTICS INC

LINEAGE CELL THERAPEUTICS INC

LCTX

0.00
  • Lineage Cell Therapeutics will hold its annual shareholder meeting in Carlsbad, California on June 10, 2026.
  • Shareholders will vote to elect seven directors, including Michael H. Mulroy, Dipti Amin, Deborah Andrews.
  • Ballot also includes ratification of Baker Tilly US as independent auditor for fiscal year ending Dec. 31, 2026.
  • Advisory vote scheduled on executive compensation for named executive officers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lineage Cell Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-191556), on April 29, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.